Pathophysiology and Treatment of Atopic Dermatitis and Psoriasis, 2nd Edition
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Molecular and Translational Medicine".
Deadline for manuscript submissions: 31 August 2024 | Viewed by 52
Special Issue Editor
Interests: atopic dermatitis; psoriasis; transcriptome
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
In the past few decades, research on atopic dermatitis and psoriasis has been very active. As a result, researchers have found that many biological and small-molecule drugs that target these two diseases are under development or are actually being prescribed to patients in clinical settings. However, more molecular, immunological, and neurological mechanisms and clinical studies are needed for precise medical treatment according to the patient's endotype and phenotype for each biomarker.
Atopic dermatitis and psoriasis are typical chronic inflammatory skin diseases. These were thought to be very different diseases caused by Th2 and Th1 immunological bias, respectively. However, many studies have revealed that the Th17/Th22 pathway in these two diseases has a common influence on disease initiation and chronicity. In addition to immunological abnormalities, atopic dermatitis and psoriasis have shared pathophysiology, such as abnormal skin barrier function, pruritus, genetic mutations, environmental influences, and neurophysiological abnormalities. Therefore, interesting results are often obtained when comparing these two diseases.
In this section, we welcome all research papers on molecular biology, immunology, neurophysiology, and biomarkers of atopic dermatitis and psoriasis, or research papers comparing the pathophysiology and treatment modalities of the two diseases.
Dr. Hyeone Kim
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- atopic dermatitis
- biomarker endotypes
- mutation
- next-generation sequencing
- phenotypes
- psoriasis
- transcriptome
